Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 7, 2013New England Journal of MedicineOpen Access

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

View Full Paper
Ask AI
Bookmark
Share

Authors

SHScott M. HammerMSMagdalena E. SobieszczykHJHolly Janes

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hammer et al. (2013) studied this question.

synapsesocial.com/papers/6a62d431a98bc91ae4c19e0chttps://doi.org/10.1056/nejmoa1310566
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)2010 · 53 citations
  2. 2Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand2009 · 3,071 citations
  3. 3Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial2005 · 2,464 citations
  4. 4Placebo‐Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV‐1 Infection2005 · 945 citations
  5. 5Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women2012 · 3,339 citations